# The Role of Endothelin in the Supine Hypertension of Autonomic Failure

> **NCT01119417** · PHASE1 · WITHDRAWN · sponsor: **Vanderbilt University**

## Conditions studied

- Hypertension
- Pure Autonomic Failure
- Multiple System Atrophy

## Interventions

- **DRUG:** BQ123
- **DRUG:** BQ123
- **DRUG:** Bq123
- **DRUG:** BQ123
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT01119417
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-05
- **Primary completion:** 2021-05
- **Final completion:** 2021-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants were enrolled
- **Last updated:** 2021-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01119417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01119417, "The Role of Endothelin in the Supine Hypertension of Autonomic Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01119417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*